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Monitoring the emergence and transmission of Pseudomonas aeruginosa strains among cystic fibrosis (CF)
patients is important for infection control in CF centers internationally. A recently developed multilocus
sequence typing (MLST) scheme is used for epidemiologic analyses of P. aeruginosa outbreaks; however, little
is known about its suitability for isolates from CF patients compared with that of pulsed-field gel electro-
phoresis (PFGE) and enterobacterial repetitive intergenic consensus-PCR (ERIC-PCR). As part of a preva-
lence study of P. aeruginosa strains in Australian CF clinics, we compared the discriminatory power and
concordance of ERIC-PCR, PFGE, and MLST among 93 CF sputum and 11 control P. aeruginosa isolates.
PFGE and MLST analyses were also performed on 30 paired isolates collected 85 to 354 days apart from 30
patients attending two CF centers separated by 3,600 kilometers in order to detect within-host evolution. Each
of the three methods displayed high levels of concordance and discrimination; however, overall lower discrim-
ination was seen with ERIC-PCR than with MLST and PFGE. Analysis of the 50 ERIC-PCR types yielded 54
PFGE types, which were related by <6 band differences, and 59 sequence types, which were classified into 7
BURST groups and 42 singletons. MLST also proved useful for detecting novel and known strains and for
inferring relatedness among unique PFGE types. However, 47% of the paired isolates produced PFGE patterns
that within 1 year differed by one to five bands, whereas with MLST all paired isolates remained identical.
MLST thus represents a categorical analysis tool with resolving power similar to that of PFGE for typing P.
aeruginosa. Its focus on highly conserved housekeeping genes is particularly suited for long-term clinical
monitoring and detecting novel strains.
Pseudomonas aeruginosa is a major determinant of morbidity
and mortality in cystic fibrosis (CF) (9, 13, 28). While many CF
patients acquire unique strains from the environment, there
are reports of patients sharing genotypically related strains in
CF centers in the United Kingdom, Europe, Canada, and Aus-
tralia, suggesting that person-to-person transmission is also a
factor (1, 3, 29, 33, 36). Furthermore, some strains are associ-
ated with poorer clinical outcomes and increased treatment
requirements (2, 3, 20). Some strains, such as clone C and
PA14, are distributed globally and found in non-CF human
infections, animals, and the natural environment (31, 34, 45).
Consequently, molecular typing techniques have become im-
portant tools in helping to control cross-infection in CF centers
and identifying transmission pathways.
Several factors require consideration when selecting a mo-
lecular typing strategy. These include discriminatory power,
reproducibility, and typeability, as well as the biological basis
for grouping similar strains, cost, and logistics (7, 40). For large
epidemiologic studies and CF reference laboratories, cost, sim-
plicity, and effectiveness have become major factors in the
choice of method. Rapid and inexpensive PCR-based typing
techniques, such as enterobacterial repetitive intergenic con-
sensus-PCR (ERIC-PCR) and random amplified polymorphic
DNA-PCR (RAPD-PCR), can be used to screen for genetic
relatedness, while the potentially more discriminatory tech-
niques of pulsed-field gel electrophoresis (PFGE) and multilo-
cus sequence typing (MLST) help confirm results (7, 32).
The high discriminatory power of PFGE makes it the “gold
standard” for DNA fingerprinting techniques. PFGE was in-
tended originally for outbreak situations involving epidemio-
logically related isolates collected over a short time period
(41). However, because single mutations can destroy or create
restriction sites, minor evolutionary events can cause substan-
tive changes in PFGE restriction profiles and generate spuri-
ous genotyping results (12). In contrast, MLST is based on
allelic variation in housekeeping genes, and while it monitors
change over just a small portion of the genome, it is highly
discriminating and provides insight into genetic structure (7).
MLST may therefore be more suitable than PFGE for strain
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surveillance in CF centers (7, 26, 43). While both PCR-based
typing techniques (ERIC-PCR) and PFGE have been com-
pared using P. aeruginosa isolates from CF patients (39), com-
parisons of MLST and PFGE have been limited to VIM-1-like
metallo--lactamase-producing strains and isolates collected
from an intensive care unit (14, 18). Consequently, little is
known about the relative performances of all three tests when
typing P. aeruginosa sputum isolates from chronically infected
CF patients.
In this study we compared ERIC-PCR, PFGE, and MLST
using isolates obtained during the first year of a national point
prevalence study of clonal P. aeruginosa strains in Australian
CF centers (cross-sectional study) (25). We also report the
results of a temporal study in which we collected isolates 3 to
12 months apart from individual patients attending two CF
centers separated from one another by 3,600 kilometers (rep-
licate study). Together our results demonstrate close concor-
dance among the three methods but draw attention to partic-
ular—and complementary—strengths associated with the
combined use of both PFGE and MLST.
MATERIALS AND METHODS
Bacterial isolates. P. aeruginosa isolates from sputum were collected as part of
a national multicenter prevalence study of clonal strains within Australian CF
centers between September 2007 and September 2008 and were identified and
stored as described previously (25). Human research ethics committees at each
of the 11 participating centers approved the study.
Controls. The Australian epidemic strains AES-I (3), AES-II (29), and AES-
III (4), the previously described Australian minor clonal strains P42, P3, P5, P58
(29), and the Tasmanian minor strain (TMS) (4) were included as controls and
supplemented with the Liverpool epidemic strain H190 (LES) (6), Manchester
strain C3425 (MAN) (21), and clone C strain CF128-1 (34).
ERIC-PCR. Initially, each isolate underwent ERIC-PCR typing as described
previously (39). Thermal cycling was performed in a Bio-Rad Mycycler personal
thermal cycler (Bio-Rad Laboratories Pty Ltd., Gladesville, Australia), and 7 l
of the amplified products was subjected to electrophoresis (80 V) in 1.2%
agarose for 180 min. Amplified products were detected by ethidium bromide
staining and visualized in a Gel Doc XR molecular imager (Bio-Rad Laborato-
ries Pty Ltd.). Comparison of ERIC-PCR banding patterns was performed using
FPQuest cluster analysis software, version 4.5 (Bio-Rad Laboratories Pty Ltd.).
Isolates producing fingerprints related by 100% (Dice coefficient/unweighted
pair-group method with arithmetic mean [UPGMA]) were allocated to the same
ERIC-PCR type.
PFGE. DNA extraction and SpeI digestion were performed using the Gene-
Path Group 3 reagent kit (Bio-Rad Laboratories Pty Ltd.) following the manu-
facturer’s instructions. Fragment separation was achieved using a CHEF DR III
system (Bio-Rad Laboratories Pty Ltd.), with a switch time ramped from 5.3 to
34.9 s over 19.5 h at 14°C. The relatedness of each PFGE fingerprint was
determined using both FPQuest cluster analysis (Dice coefficient/UPGMA) and
the Tenover criteria (41). Isolates producing PFGE fingerprints related by80%
and with 6 band differences were categorized as the same PFGE type (PT).
MLST. The reagents, primers, and reaction conditions used for MLST were
identical to those described on the P. aeruginosa MLST website (http://pubmlst
.org/paeruginosa/). Thermal cycling was performed in a Bio-Rad Mycycler per-
sonal thermal cycler, and cycle sequencing was undertaken by the Australian
Genome Research Facility using the BigDye Terminator v3.1 cycle sequencing
kit and an AB3730xl genetic analyzer (Applied Biosystems Inc., Foster City, CA).
Sequence verification and editing were performed using Sequence Scanner v1.0
(Applied Biosystems Inc.) and Vector NTI Advance 11.0 (Invitrogen Australia
Pty Ltd.) software. Sequence type (ST) assignment was performed on the P.
aeruginosa MLST website, START2 software generated a UPGMA dendrogram
of the allelic profiles, and the eBURST algorithm inferred clonal relationships
between each ST (10, 19). STs sharing 6 alleles were allocated to the same
BURST group (BG).
Statistical analysis. The discriminatory power and the congruence between
ERIC-PCR, MLST (STs and BGs), and PFGE (PTs) were calculated with
EpiCompare v1.0 software (Ridom GmbH, Wurzburg, Germany), using Simp-
son’s index of diversity (with 95% confidence intervals), the adjusted Rand index,
and the Wallace coefficient (5, 15, 16, 17, 44). The adjusted Rand index provides
quantification of congruence between methods, and the Wallace coefficient pro-
vides, for a given typing method, an estimate of how much new information
would be provided by another method (5). Thus, for the Wallace coefficient,
bidirectional values are provided. For MLST analyses, both ST and BG were
used to examine for concordance.
RESULTS
Cross-sectional study. (i) ERIC-PCR. Initially, 1,120 P.
aeruginosa sputum isolates from 346 CF patients (277 adults
18 years of age) and the 11 control strains were typed by
ERIC-PCR, and 117 discrete ERIC-PCR types were identi-
fied. Subsequently, 93 isolates from 91 Australian CF patients
(78 adults) and 11 control strains were selected for PFGE and
MLST analyses. These represented 50 different ERIC-PCR
types (Table 1; see Fig. S1 in the supplemental material) and
included (i) 20 isolates categorized by ERIC-PCR as either
AES-I or AES-II strains and selected randomly from the two
most geographically separated adult CF centers, (ii) 20 isolates
from five centers with ERIC-PCR types matching one of eight
clones (P3, P5, P42, P58, AES-III, TMS, LES, and clone C)
described in Materials and Methods, (iii) 31 isolates from 10
centers representing 13 novel ERIC-PCR strains detected in
clusters involving more than one patient, (iv) 22 unrelated
strains selected randomly from 4 CF centers, and (v) 11 control
isolates.
(ii) PFGE. SpeI digestion was performed successfully on all
but one of the 104 selected isolates, resulting in 80 different
banding patterns, which were grouped into 54 PTs (see Fig. S2
in the supplemental material). Table 1 shows that PFGE and
ERIC-PCR gave concordant typing results for 92% (95/103) of
the clinical and control isolates. All eight discordant typing
results involved clinical isolates. These included one each of
the epidemic strains LES (E15) and AES-II (E25) and multiple
unrelated PTs for ERIC-PCR types E26, E31, and E33.
(iii) MLST and eBURST analysis. Table 1 shows that MLST
and ERIC-PCR produced concordant typing results for 83%
(86/104) of the tested isolates. Of the 59 STs detected (Table
1; see Fig. S3 in the supplemental material), 37 (63%) repre-
sented novel STs not listed previously on the P. aeruginosa
MLST website. One ST (ST119) had a 2-base-pair deletion
within the mutL locus (nucleotides [nt] 119/120; this was a
potential mutator strain [30]), which could not be analyzed by
the MLST website or eBURST. BURST analysis of the re-
maining 103 isolates identified seven different BGs (A to G)
and 42 singletons (Table 2). Eighty-eight isolates (85%) had
concordant ERIC-PCR and eBURST analyses. As with PFGE,
one of the clinical E25 isolates was not typed as an AES-II
(ST775) strain, E26 was also divided into BG-B and ST389,
and E31 was separated into four unrelated STs (ST803, ST508,
ST804, and ST822). Other discrepancies between ERIC-PCR
and MLST were noted among ERIC-PCR types E32 to E35,
which were grouped into BG-E and ST179, and six unrelated
ERIC-PCR types were clustered into BG-D (E01 and E31),
BG-C (E25 and E40), and BG-A (E43 and E44) (Tables 1 and
2; see Fig. S3 in the supplemental material).
(iv) Comparison of ERIC-PCR, PFGE, and MLST. Com-
parison of the typing results generated by the three techniques
revealed few discrepancies (Table 1). The LES E15 isolates
were identical by MLST (ST146), and discordance involving
264 KIDD ET AL. J. CLIN. MICROBIOL.
 o
n
 O
ctober 21, 2015 by UQ Library
http://jcm.asm.org/
D
ow
nloaded from
 
E32 to E36 isolates was also observed. eBURST analysis al-
lowed clonal relationships between six unrelated PTs (PT01,
PT32, PT24, PT43, PT46, PT47) clustered into BG-D, BG-C,
and BG-A to be inferred.
Simpson’s index of diversity was used to determine the dis-
criminatory power of ERIC-PCR, PFGE, MLST, and MLST
following eBURST analysis. Diversity indices and their 95%
confidence intervals are presented in Table 3. The discrimina-
tory powers of the typing methods were equivalent. However,
to compare the congruency between type assignments, the
adjusted Rand index and the Wallace coefficient provided ad-
ditional information (Table 3). Overall, there was strong cor-
relation between the information provided by all typing meth-
ods. Using the adjusted Rand index, the highest level of
agreement was observed between PFGE and MLST, whether
analyzed as STs or following eBURST analysis (0.897 and
0.921). Similarly, Wallace coefficients for PFGE and MLST
indicate strong bidirectional correspondence (0.847 to 0.965)
between types generated by these methods. However, despite
similar Simpson’s diversity indices, ERIC-PCR was less con-
cordant with PFGE and MLST than PFGE and MLST were
with each other. Both MLST and PFGE were better predictors
of ERIC-PCR type than ERIC-PCR was of MLST and/or
PFGE type.
Replicate study. Thirty random isolate pairs obtained sev-
eral months apart from 30 patients attending two Australian
adult CF centers participating in the national clonal P. aerugi-
nosa prevalence study (26) and separated by 3,600 kilometers
were selected to undergo PFGE and MLST genotyping. At the
baseline sputum collection, adult participants had been in-
fected with P. aeruginosa for 6 to 33 (mean, 14.7; standard
deviation [SD], 6.4) years. The second isolate came from spu-
tum collected 85 to 354 (mean, 203; SD, 52) days after the
baseline sample. According to ERIC-PCR typing, 10 paired
isolates were AES-I, 10 were AES-II, and 10 represented
unique, unrelated strains. However, PFGE and MLST both
showed that one AES-II isolate pair belonged to an unrelated
strain (see “Cross-sectional study” above). MLST identified 13
STs among the 30 paired isolates, while among these same
isolate pairs, PFGE yielded 31 different band patterns, which
were grouped into 13 distinct PTs. Although the isolates rep-
resented by the 13 different PTs and 13 different STs were the
same, 14 (47%) of the 30 isolate pairs diverged by one to five
PFGE bands between the first and second sputum collections
(Table 4), whereas the ST remained stable for all 30 isolate
pairs.
DISCUSSION
ERIC-PCR, PFGE, and MLST provide measures of genetic
diversity, but they are not equivalent. ERIC-PCR reveals a
profile of DNA fragments of different sizes based, in principle
TABLE 1. P. aeruginosa strain typing results obtained using ERIC-
PCR, PFGE, and MLST
Corresponding
control straina
ERIC-PCR
type (n) PFGE type(s) (n) MLST ST(s) (n)
E01 (1) PT01 (1) 791 (1)
E02 (1) PT02 (1) 792 (1)
E03 (1) PT03 (1) 793 (1)
E04 (1) PT04 (1) 794 (1)
E05 (1) PT05 (1) 795 (1)
E06 (1) PT06 (1) 377 (1)
E07 (1) PT07 (1) 796 (1)
E08 (1) PT08 (1) 797 (1)
E09 (1) PT09 (1) 798 (1)
E10 (1) PT10 (1) 655 (1)
E11 (1) PT11 (1) 821 (1)
E12 (1) PT12 (1) 259 (1)
E13 (1) PT13 (1) 776 (1)
E14 (1) PT14 (1) 777 (1)
LES E15 (2) PT15 (1), PT54 (1) 146 (2)
E16 (1) PT16 (1) 778 (1)
E17 (1) PT17 (1) 789 (1)
E18 (1) PT18 (1) 790 (1)
E19 (1) PT19 (1) 494 (1)
E20 (1) Nontypeable (1) 805 (1)
E21 (1) PT20 (1) 780 (1)
E22 (1) PT21 (1) 802 (1)
E23 (1) PT22 (1) 253 (1)
AES-I E24 (11) PT23 (11) 649 (11)
AES-II E25 (11) PT24 (10), PT25 (1) 775 (10), 266 (1)
P3 E26 (5) PT26 (4), PT27 (1) 799 (1), 800 (3),
389 (1)
P5 E27 (3) PT28 (3) 262 (3)
AES-III E28 (2) PT29 (2) 242 (2)
TMS E29 (4) PT30 (4) 787 (1), 788 (3)
P42 E30 (5) PT31 (5) 801 (5)
P58 E31 (5) PT32 (2), PT33 (1),
PT34 (1), PT35 (1)
803 (2), 508 (1),
804 (1), 822 (1)
E32 (2) PT36 (2) 179 (2)
E33 (3) PT36 (1), PT37 (1),
PT39 (1)
179 (1), 155 (2)
E34 (2) PT37 (2) 155 (1), 786 (1)
E35 (1) PT38 (1) 155 (1)
E36 (6) PT40 (6) 274 (5), 781 (1)
E37 (1) PT40 (1) 274 (1)
E38 (6) PT41 (6) 782 (3), 783 (1),
784 (1), 785 (1)
E39 (1) PT42 (1) 807 (1)
E40 (1) PT43 (1) 808 (1)
E41 (1) PT44 (1) 809 (1)
Clone C E42 (2) PT45 (2) 17 (2)
E43 (1) PT46 (1) 261 (1)
E44 (1) PT47 (1) 810 (1)
E45 (1) PT48 (1) 236 (1)
E46 (1) PT49 (1) 277 (1)
E47 (1) PT50 (1) 260 (1)
E48 (1) PT51 (1) 254 (1)
E49 (1) PT52 (1) 119 (1)b
MAN E50 (1) PT53 (1) 217 (1)
a A selection of previously known epidemic and minor clonal CF P. aeruginosa
strains (3, 4, 6, 21, 29, 34).
b ST119 represents a clinical isolate with a 2-base-pair deletion within the
mutL locus (nt 119/120) which could not be assigned a formal sequence type
using the MLST website.
TABLE 2. Summary of eBURST analysis
eBURST group MLST STs No. ofisolates
A 261, 810 2
B 799, 800 4
C 775, 808 11
D 791, 803 3
E 155, 786 5
F 787, 788 4
G 782, 783, 784, 785 6
Singletons n  42 68
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(but see reference 46), on the genomic locations of specific
repetitive sequences; PFGE reveals restriction site polymor-
phisms arising from the genomic locations of SpeI sites; and
MLST provides a measure of nucleotide polymorphism based
on the DNA sequences of seven housekeeping genes. The first
two approaches capture a genome-wide perspective on diver-
sity, with differences between strains arising from a potentially
wide range of genetic changes, from point mutations through
large-scale inter- and intragenomic recombinational events,
although the specific causes of any differences can only be
presumed. MLST reveals highly detailed information on ge-
netic changes in specific housekeeping genes and thus provides
direct insight into evolutionary changes of the core genome.
While MLST is highly portable and provides direct access to
the tools and approaches of population genetics, it sheds little
light on specific genetic changes beyond the targeted loci.
Despite the differences in underlying genetic “currency,” the
three different techniques demonstrate a remarkably high level
of concordance, discrimination, and typeability. The limited
variability of MLST combined with its ready portability sug-
gests that it is better suited than PFGE for long-term strain
surveillance within CF centers and for identification of specific
evolutionary lineages. In addition, MLST proved useful for
detecting novel and previously known strains and for inferring
relatedness among isolates that appeared to be unrelated by
PFGE.
Several other studies also have reported temporal variation
in CF P. aeruginosa isolate PFGE band patterns (22, 32, 38)
and point to evidence of within-host evolution. In contrast,
MLST, as shown here and elsewhere (43), reveals evidence of
long-term stability. Such findings, while seemingly contradic-
tory, are readily reconciled by the fact that MLST reveals the
identity of the evolving lineage, while PFGE, by virtue of its
potential to sample a greater range of genetic changes (large-
scale insertions and deletions as well as point mutations that
create or destroy restriction sites), stands to shed light on the
dynamic nature of the P. aeruginosa genome. The variation in
PTs that we observed among some STs (e.g., ST146, ST155,
and ST179) likely reflects genetic events including intra- and
intergenomic recombination within variable regions of the ge-
nome or the accessory gene pool. Such changes could have
significant implications for the evolution of P. aeruginosa.
Simpson’s index was used to assess each method’s ability to
assign a different type to two randomly sampled strains (17),
although caution in interpreting the results is required because
our sample was not randomly collected. Nonetheless, overall,
the discriminatory power of each method was high (0.96) (7),
with each method showing equivalent levels of discrimination.
Despite reservations regarding the appropriateness of Simp-
son’s index, two other statistical approaches (the adjusted
Rand index and the Wallace coefficient) also revealed a high
level of congruence between ERIC-PCR, PFGE, and MLST.
PFGE and eBURST analyses showed the strongest correla-
tion, suggesting that using both techniques together may be
redundant (i.e., additional information provided by performing
the second typing method was minimal). We note that our
finding of MLST having the greatest discriminatory power is at
odds with one previous study, which found PFGE to be the
superior methodology for detecting genetic relatedness be-
tween P. aeruginosa strains in perirectal surveillance swabs
from patients nursed in intensive care units at a single center
(18). Differences in the nature and origins of the strains and/or
the interpretative criteria used for defining PTs may help ex-
plain our contradictory findings with CF sputum isolates.
In the current study, the level of congruence between the
techniques was lower for ERIC-PCR than for MLST and
PFGE (Table 3). Nevertheless, ERIC-PCR did perform well
and in our hands and appears to be a more reliable typing
strategy for P. aeruginosa than are other novel PCR-based
typing methodologies (11). While clonality of P. aeruginosa
may be overestimated by ERIC-PCR, suggesting that an addi-
tional typing method should be used to confirm relationships
between isolates displaying indistinguishable types, we also
observed that compared to MLST, both ERIC-PCR and
PFGE may occasionally overly discriminate for some STs (e.g.,
ST155, ST179, and ST274). Taken together, these results draw
TABLE 3. Number of types, Simpson’s index of diversity, adjusted Rand indices, and Wallace coefficients for ERIC-PCR, PFGE,
MLST sequence types, and BURST groups
Method No. oftypes
Simpson’s index of diversity
(95% confidence interval)
Adjusted Rand’s coefficient Wallace coefficient
ERIC-PCR PFGE MLST ST MLST BG ERIC-PCR PFGE MLST ST MLST BG
ERIC-PCR 50 0.965 (0.951–0.979) 1.000 0.893 0.813 0.838 1.000 0.856 0.738 0.840
PFGE 54 0.968 (0.954–0.982) 1.000 0.897 0.921 0.941 1.000 0.847 0.965
MLST ST 59 0.972 (0.958–0.986) 1.000 0.892 0.920 0.960 1.000 1.000
MLST BG 50 0.965 (0.951–0.980) 1.000 0.849 0.886 0.811 1.000
TABLE 4. PFGE band differences in 30 paired sputum
P. aeruginosa isolate sets collected 85 to 354 days apart
from chronically infected adults with CF
Strain (no. of isolates)
Total no. of PFGE
band differences vs
baseline isolate
No. of
individuals
AES-1 (20) 0 7
1 1
2 2
AES-2 (18) 0 5
1 0
2 3
3 1
Unrelated strains (22) 0 4
1 1
2 1
3 3
4 1
5 1
Total 30
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further attention to the fact that different typing methods,
which are each based on different attributes of genetic varia-
tion, are unlikely to demonstrate 100% concordance.
During this study we confirmed the presence of several novel
and known strains that were previously undetected in Austra-
lian CF patients. Among these strains were LES (ST146),
clone C (ST17), PA14 (ST253), ST179, and ST155. These
strains are distributed widely throughout the Northern Hemi-
sphere and have been found in the natural environment, in
animals, and in different patient groups (1, 8, 23, 36, 42, 43, 45).
Using the P. aeruginosa MLST website, we have also estab-
lished that several Australian CF strains (e.g., AES-I [ST649],
ST274, ST260, and ST254) are in CF and non-CF settings
elsewhere in the world (24, 27). While most of these strains are
distinguishable by PFGE and ERIC-PCR, isolates belonging to
ST155 and ST179 are less readily distinguished. Variations in
RAPD and PFGE patterns in ST155 and ST179 isolates from
a Canadian CF study spanning 19 years have been published
recently on the P. aeruginosa MLST website (37). The detec-
tion international strains within Australian CF patients pro-
vides further evidence for the global distribution of several
major P. aeruginosa clones (31, 35, 42, 45) and for the porta-
bility of MLST (7). These observations are important for un-
derstanding local and global epidemiology and identifying
transmission pathways. Had MLST not been used in the cur-
rent study, then the presence of PA14, ST155, and ST179 in
Australia is likely to have gone undetected.
To our knowledge this study represents the most extensive
evaluation of ERIC-PCR, PFGE, and MLST with P. aerugi-
nosa CF isolates. Generally, ERIC-PCR, PFGE, and MLST
were concordant, provided that isolates were grouped into
PFGE types related by 6 bands and into BGs sharing at least
6 alleles. Advantages of MLST are its (i) utility and unambig-
uous, categorical approach to interpretation, (ii) stability over
time and in various CF center settings, and (iii) capacity to
identify novel strains and to infer clonal relatedness in epide-
miologically unrelated isolates. The increasing availability of
affordable high-throughput sequencing methods draws atten-
tion to the potential for MLST and other sequence-based typ-
ing methods to complement PFGE as a typing strategy.
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